The Buck Institute for Research on Aging has received a $3.5 million federal grant to lead the first-ever double-blind, randomized, placebo-controlled clinical trial to understand the effects of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback